Open Access

Very low dose of rivaroxaban. It is time for a new era.

Seminar Presentation

About the speaker

Professor Joao Morais

Leiria Hospital Centre, Leiria (Portugal)
14 presentations
0 follower

4 more presentations in this session

Welcome & Introduction .

Speaker: Doctor G. Vilahur (Barcelona, ES)


Dual anti platelet therapy duration? Very short or very long?

Speaker: Professor J. ten Berg (Nieuwegein, NL)


De-escalation of monotherapy with P2Y12 inhibitor. An alternative approach.

Speaker: Doctor J. Ferreiro (Hospitalet De Llobregat, ES)


The bleeding risk the true game changer.

Speaker: Professor T. Geisler (Tuebingen, DE)


Access the full session

Welcome and Session 1: From ACS to chronic coronary artery disease. The transition period

Speakers: Professor J. Morais, Doctor G. Vilahur, Professor J. ten Berg, Doctor J. Ferreiro, Professor T. Geisler

About the event


Hot topics and new insights for Thrombosis 2022

17 March 2022 17:00 CET

Related content

ACVC Premium Access

The patient with acute myocarditis.

19 March 2022

Open Access

First-line cryoablation for Atrial Fibrillation: Turning evidence into practice.

27 August 2021

Open Access

Your treatment approach in clinical practice.

27 August 2021

ESC 365 is supported by

logo Novo Nordisk